Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $395000.0.

  • Mirum Pharmaceuticals' Other Non Operating Income rose 13633.85% to $395000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 18716.9%. This contributed to the annual value of $1.2 million for FY2024, which is 10247.17% up from last year.
  • Mirum Pharmaceuticals' Other Non Operating Income amounted to $395000.0 in Q3 2025, which was up 13633.85% from $86000.0 recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Other Non Operating Income registered a high of $2.1 million during Q1 2025, and its lowest value of -$49.1 million during Q2 2023.
  • In the last 5 years, Mirum Pharmaceuticals' Other Non Operating Income had a median value of -$16500.0 in 2021 and averaged -$2.5 million.
  • The largest annual percentage gain for Mirum Pharmaceuticals' Other Non Operating Income in the last 5 years was 78854.17% (2023), contrasted with its biggest fall of 387798.31% (2023).
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Other Non Operating Income stood at -$17000.0 in 2021, then crashed by 3358.82% to -$588000.0 in 2022, then soared by 324.83% to $1.3 million in 2023, then plummeted by 82.53% to $231000.0 in 2024, then surged by 71.0% to $395000.0 in 2025.
  • Its Other Non Operating Income stands at $395000.0 for Q3 2025, versus $86000.0 for Q2 2025 and $2.1 million for Q1 2025.